Clinical Trials Logo

Common Wart clinical trials

View clinical trials related to Common Wart.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT05115669 Completed - Plantar Wart Clinical Trials

Safety & Effectiveness of Wortie Freeze Plus in Common and Plantar Warts

Start date: October 12, 2021
Phase: N/A
Study type: Interventional

This is a Post-Market clinical Follow-up investigation to evaluate the safety and performed of the medical device Wortie Freeze Plus in the treatment of common and plantar warts.

NCT ID: NCT03812510 Completed - Common Wart Clinical Trials

Safety Study of A-101 Topical Solution for the Treatment of Common Warts

Start date: February 7, 2019
Phase: Phase 3
Study type: Interventional

A Phase 3 Study of A-101 Topical Solution Applied Twice a Week in Subjects with Common Warts

NCT ID: NCT03691831 Completed - Common Wart Clinical Trials

A Study of A-101 Topical Solution for the Treatment of Common Warts

Start date: September 13, 2018
Phase: Phase 3
Study type: Interventional

Phase 3 Study of A-101 Topical Solution in Subjects with Common Warts

NCT ID: NCT03687372 Completed - Common Wart Clinical Trials

Study of A-101 Topical Solution for the Treatment of Common Warts

Start date: September 17, 2018
Phase: Phase 3
Study type: Interventional

A Phase 3 Study of A-101 Topical Solution Applied Twice a Week in Subjects with Common Warts

NCT ID: NCT03487549 Completed - Virus Diseases Clinical Trials

Cantharidin and Occlusion in Verruca Epithelium

COVE-1
Start date: March 27, 2018
Phase: Phase 2
Study type: Interventional

This is a Phase 2, open label study (Study number VP-102-105; referred to as COVE-1 [Cantharidin and Occlusion in Verruca Epithelium]) to evaluate the efficacy, safety and tolerability of VP-102 treatment in subjects with common warts. This study has two Cohorts.

NCT ID: NCT03278028 Completed - Common Wart Clinical Trials

A Study of A-101 Topical Solution Administered Twice a Week in Subjects With Common Warts

Start date: July 13, 2017
Phase: Phase 2
Study type: Interventional

The primary objective of this study is to evaluate the effectiveness of A-101 compared to Vehicle when applied to 1 Target common wart on the trunk or extremities twice a week.

NCT ID: NCT03210337 Completed - Common Wart Clinical Trials

A Phase2 of A-101 Topical Solution in Subjects With Common Warts

Start date: August 1, 2017
Phase: Phase 2
Study type: Interventional

The primary objective of this study is to evaluate the effectiveness of A-101 compared to vehicle when applied to 1 common target wart on the trunk or extremities.

NCT ID: NCT03183765 Completed - Plantar Wart Clinical Trials

Intralesional Measles, Mumps, Rubella (MMR) Vaccine Versus Cryotherapy in Treatment of Multiple Common and Planter Warts

Start date: August 1, 2017
Phase: Phase 4
Study type: Interventional

Warts are benign epidermal tumors caused by human papilloma virus, which are epitheliotropic non-enveloped double stranded DNA viruses. Transmission of warts occurs from direct person-to-person contact or indirectly by fomites . Warts appear in various forms including verruca vulgaris, plane, plantar, filiform, digitate and periungual.

NCT ID: NCT00328991 Completed - Plantar Wart Clinical Trials

Clinical Trial Evaluating Efficacy of Duct Tape for Treatment of Warts

Start date: October 2004
Phase: N/A
Study type: Interventional

This study is a double-blinded, controlled clinical intervention trial to evaluate the efficacy of duct tape occlusions therapy for the treatment of common warts. 80 patients completed this study, and were randomized 1:1 to receive pads which contained either moleskin+transparent duct tape or moleskin alone. The patients wore the pad over the target wart for 7 days at a time, removed the pad on the evening of the 7th day, and replaced the pad on the 8th day. This cycle was repeated for 8 weeks or until the wart resolved. The hypothesis was that duct tape occlusion therapy would be more therapeutic than moleskin for the treatment of the common wart. However, in our study there was only 21% resolution rate in the duct tape arm vs. 22% in the control group.